Covid-19 action plan – 2021 update

In line with our previous Covid-19 Action Plan, Newcells Biotech has continued to review and invest in measures to reduce the risk to its staff and our wider community from the Covid-19 virus.

We have reviewed our policies and procedures in light of the recent Government restrictions and implemented further measures including improved physical barriers, biosecurity procedures and work patterns to enable us to continue servicing our customers while maintaining the safety of our staff.

We wish all of our customers, suppliers and partners a safe and healthy 2021.

Dr Mike Nicholds
CEO
Newcells Biotech

A message to our customers, collaboration partners and colleagues

You might also be interested in…